Koch Hein, E.C.; Vilbert, M.; Hirsch, I.; Fernando Ribeiro, M.; Muniz, T.P.; Fournier, C.; Abdulalem, K.; Saldanha, E.F.; Martinez, E.; Spreafico, A.;
et al. Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers 2023, 15, 4312.
https://doi.org/10.3390/cancers15174312
AMA Style
Koch Hein EC, Vilbert M, Hirsch I, Fernando Ribeiro M, Muniz TP, Fournier C, Abdulalem K, Saldanha EF, Martinez E, Spreafico A,
et al. Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers. 2023; 15(17):4312.
https://doi.org/10.3390/cancers15174312
Chicago/Turabian Style
Koch Hein, Erica C., Maysa Vilbert, Ian Hirsch, Mauricio Fernando Ribeiro, Thiago P. Muniz, Cynthia Fournier, Khaled Abdulalem, Erick F. Saldanha, Erika Martinez, Anna Spreafico,
and et al. 2023. "Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre" Cancers 15, no. 17: 4312.
https://doi.org/10.3390/cancers15174312
APA Style
Koch Hein, E. C., Vilbert, M., Hirsch, I., Fernando Ribeiro, M., Muniz, T. P., Fournier, C., Abdulalem, K., Saldanha, E. F., Martinez, E., Spreafico, A., Hogg, D. H., Butler, M. O., & Saibil, S. D.
(2023). Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers, 15(17), 4312.
https://doi.org/10.3390/cancers15174312
